Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Non Operating Income (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Non Operating Income for 6 consecutive years, with -$30221.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 148.12% year-over-year to -$30221.0, compared with a TTM value of -$199671.0 through Sep 2025, down 135.93%, and an annual FY2024 reading of -$5708.0, down 101.5% over the prior year.
  • Non Operating Income was -$30221.0 for Q3 2025 at Xenetic Biosciences, down from $35709.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $356161.0 in Q4 2023 and bottomed at -$205237.0 in Q4 2024.
  • Average Non Operating Income over 3 years is $34635.9, with a median of $21122.0 recorded in 2023.
  • Peak annual rise in Non Operating Income hit 9529.73% in 2024, while the deepest fall reached 157.62% in 2024.
  • Year by year, Non Operating Income stood at $356161.0 in 2023, then crashed by 157.62% to -$205237.0 in 2024, then surged by 85.28% to -$30221.0 in 2025.
  • Business Quant data shows Non Operating Income for XBIO at -$30221.0 in Q3 2025, $35709.0 in Q2 2025, and $78.0 in Q1 2025.